Autoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary Fibrosis
出版年份 2015 全文链接
标题
Autoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary Fibrosis
作者
关键词
Autoantibodies, Pulmonary fibrosis, Pulmonology, B cells, Antibodies, Cancer treatment, Lung transplantation, Walking
出版物
PLoS One
Volume 10, Issue 6, Pages e0127771
出版商
Public Library of Science (PLoS)
发表日期
2015-06-18
DOI
10.1371/journal.pone.0127771
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- B cell activating factor is central to bleomycin- and IL-17-mediated experimental pulmonary fibrosis
- (2015) Antoine François et al. JOURNAL OF AUTOIMMUNITY
- C-X-C Motif Chemokine 13 (CXCL13) Is a Prognostic Biomarker of Idiopathic Pulmonary Fibrosis
- (2014) Louis J. Vuga et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Identification of Annexin 1 as a Novel Autoantigen in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
- (2014) K. Kurosu et al. JOURNAL OF IMMUNOLOGY
- Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis
- (2014) Daryle J DePianto et al. THORAX
- An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
- (2013) William D. Travis et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Plasma B Lymphocyte Stimulator and B Cell Differentiation in Idiopathic Pulmonary Fibrosis Patients
- (2013) J. Xue et al. JOURNAL OF IMMUNOLOGY
- Type V Collagen Induced Tolerance Suppresses Collagen Deposition, TGF-β and Associated Transcripts in Pulmonary Fibrosis
- (2013) Ragini Vittal et al. PLoS One
- Peripheral Blood Mononuclear Cell Gene Expression Profiles Predict Poor Outcome in Idiopathic Pulmonary Fibrosis
- (2013) J. D. Herazo-Maya et al. Science Translational Medicine
- Patients with Idiopathic Pulmonary Fibrosis with Antibodies to Heat Shock Protein 70 Have Poor Prognoses
- (2012) Rehan A. Kahloon et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Acute Exacerbation of Idiopathic Pulmonary Fibrosis
- (2012) Dong Soon Kim CLINICS IN CHEST MEDICINE
- Severe interstitial lung disease in connective tissue disease: rituximab as rescue therapy
- (2012) Gregory J. Keir et al. EUROPEAN RESPIRATORY JOURNAL
- Role of lymphoid chemokines in the development of functional ectopic lymphoid structures in rheumatic autoimmune diseases
- (2012) Elisa Corsiero et al. IMMUNOLOGY LETTERS
- Intravenous Immune Globulin in Autoimmune and Inflammatory Diseases
- (2012) Erwin W. Gelfand NEW ENGLAND JOURNAL OF MEDICINE
- Signaling pathways in aged T cells – A reflection of T cell differentiation, cell senescence and host environment
- (2012) Jörg J. Goronzy et al. SEMINARS IN IMMUNOLOGY
- Peripheral Blood Proteins Predict Mortality in Idiopathic Pulmonary Fibrosis
- (2011) Thomas J. Richards et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The distribution of immunomodulatory cells in the lungs of patients with idiopathic pulmonary fibrosis
- (2011) Gerard J Nuovo et al. MODERN PATHOLOGY
- The HLA Class II Allele DRB1*1501 Is Over-Represented in Patients with Idiopathic Pulmonary Fibrosis
- (2011) Jianmin Xue et al. PLoS One
- Identification of Periplakin as a New Target for Autoreactivity in Idiopathic Pulmonary Fibrosis
- (2010) Camille Taillé et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Rheumatoid Arthritis: A Role for Immunosenescence?
- (2010) Tamsin M. Lindstrom et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
- (2010) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD28 Down-Regulation on Circulating CD4 T-Cells Is Associated with Poor Prognoses of Patients with Idiopathic Pulmonary Fibrosis
- (2010) Syed R. Gilani et al. PLoS One
- The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)
- (2010) Johannes Brettschneider et al. PLoS One
- B-lymphocyte stimulator/a proliferation-inducing ligand heterotrimers are elevated in the sera of patients with autoimmune disease and are neutralized by atacicept and B cell maturation antigen-immunoglobulin
- (2010) Stacey R Dillon et al. ARTHRITIS RESEARCH & THERAPY
- Mechanisms of Immune Complex–Mediated Neutrophil Recruitment and Tissue Injury
- (2009) Tanya N. Mayadas et al. CIRCULATION
- Rituximab therapy in autoimmune pulmonary alveolar proteinosis
- (2009) R. Borie et al. EUROPEAN RESPIRATORY JOURNAL
- The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus
- (2009) Michael P. Cancro et al. JOURNAL OF CLINICAL INVESTIGATION
- Serum BLC/CXCL13 Concentrations and Renal Expression of CXCL13/CXCR5 in Patients with Systemic Lupus Erythematosus and Lupus Nephritis
- (2009) H.-T. LEE et al. JOURNAL OF RHEUMATOLOGY
- Rituximab treatment of the anti-synthetase syndrome—a retrospective case series
- (2009) Marthe Sem et al. RHEUMATOLOGY
- Alterations in peripheral blood memory B cells in patients with active rheumatoid arthritis are dependent on the action of tumour necrosis factor
- (2009) M Margarida Souto-Carneiro et al. ARTHRITIS RESEARCH & THERAPY
- Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor α, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor
- (2008) Inmaculada Rioja et al. ARTHRITIS AND RHEUMATISM
- Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: Delineation by expression of CD27, IgD, and CD95
- (2008) Annett M. Jacobi et al. ARTHRITIS AND RHEUMATISM
- Infections and Autoimmunity: A Panorama
- (2008) V. Pordeus et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More